Skip to main content
MedMen Enterprises Inc. logo

MedMen Enterprises Inc. — Investor Relations & Filings

Ticker · MMNFQ ISIN · CA58507M1077 LEI · 254900FFBPONQV04RD14 CSE Wholesale and retail trade
Open in API
Filings indexed 518 across all filing types
Latest filing 2020-12-02 Regulatory Filings
Country CA Canada
Listing CSE MMNFQ

About MedMen Enterprises Inc.

https://medmen.com/

MedMen Enterprises Inc. is a cannabis retailer that historically operated dispensaries and cultivation facilities across key U.S. markets, including California, Nevada, Illinois, Massachusetts, and New York. The company focused on delivering a modern, high-end retail experience, offering a curated selection of cannabis products such as flower, pre-rolls, vapes, edibles, concentrates, and CBD wellness items. Its business model emphasized transparency, knowledgeable staff, and seamless online ordering with in-store pickup. As of May 2024, MedMen Enterprises Inc. has filed for bankruptcy and initiated receivership proceedings in California.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the filing of financial results for the fiscal year ended December 31, 2018, and provides a corporate update including details about a cease trade order, settlement of a legal matter, a failed transaction, and debt financing. It references the company's audited consolidated financial statements and management's discussion and analysis available on SEDAR but does not itself contain the full annual report or detailed financial statements. The document is about reporting the filing status and corporate updates rather than presenting the full annual report. It is longer than 5,000 characters but primarily serves as an announcement of filings and corporate events rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and update that does not neatly fit into other categories like Annual Report (10-K) or Interim Report (IR).
2020-12-02 English
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 19, 2020, for MedMen Enterprises Inc. It reports the creation of a direct financial obligation under an Unsecured Convertible Facility, detailing the issuance of convertible debentures and warrants. The content focuses on financing activities, including terms of the convertible debentures, conversion prices, interest rates, and issuance of warrants. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a call transcript, management report, or governance information. It clearly relates to capital raising and financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (6661 characters) supports it being a substantive filing rather than a brief announcement or certification. Confidence is high given the clear focus on financing details.
2020-11-27 English
News release - English.pdf
Regulatory Filings
2020-11-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new product line (Viola cannabis strains) by MedMen Enterprises Inc. It contains no financial data, no regulatory or shareholder meeting information, no management or board changes, no earnings or financial results, and no legal or capital structure updates. It is a marketing and product launch announcement rather than a financial or regulatory filing. Therefore, it does not fit into any of the specific financial or regulatory filing categories. The best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2020-11-23 English
Material contracts - Credit agreements.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'First Amendment to Second Amended and Restated Securities Purchase Agreement' and contains detailed legal language amending an existing securities purchase agreement. It includes definitions, amendments to terms, conditions to effectiveness, reaffirmations, and signatures from multiple parties. The content is focused on changes to financing agreements, incremental advances, and related terms. There is no indication of financial statements, audit results, earnings data, or shareholder meeting materials. The document is a formal amendment to a financing agreement, which fits the category of Capital/Financing Update (CAP). The length (15,000 characters) and detailed content confirm it is the amendment itself, not just an announcement or summary. Therefore, the appropriate classification is CAP with high confidence.
2020-11-18 English
Material contracts - Credit agreements.pdf
Regulatory Filings
2020-11-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.